Socrates Health Solutions

What Socrates Health Solutions does

Socrates Health Solutions is a Dallas-based, privately held medical device company founded in 2013 by Scott J. Smith to develop non-invasive blood glucose monitoring technology intended for diabetes management and athletic performance use cases. Its core product line, marketed under the "Companion" sub-brand, comprises three device variants: CompanionCM, a continuous monitor targeted at people with Type 1 diabetes requiring intensive management; CompanionSR, a single-read device for moderate Type 2 diabetes management; and CompanionLS, a continuous lifestyle monitor for fitness- and performance-minded consumers. The proprietary technology is described as eliminating the need for needle insertions and finger pricks for calibration while providing real-time glucose readings, predictive alerts at critical highs and lows, mobile device connectivity, historical data capture, and secure data sharing with family members and providers.

The business model is direct hardware device sales once regulatory clearance is achieved; no pricing has been disclosed and products are not currently for sale. The go-to-market approach is community-led, emphasizing mission-aligned supporters, athlete-community partnerships, and an accredited-investor raise rather than traditional paid advertising. Equity backers include the NFL Players Association, OneTeam Partners (lead investor), Green Park & Golf Ventures, and Health Wildcatters. The headcount is reported at 1–10, and the leadership combines repeat medtech operators (Smith with prior VISICU IPO/sale experience; Chairman Douglas Sutherland formerly CFO of Skype and Chair of IWG plc), a research-heavy CSO (Peter Haaland with 40+ patents and DARPA/IARPA tenure), and board members with telehealth and legal pedigree (Michael Gorton, Teladoc founder; Patrick Kinder, General Counsel of Othram). FDA clearance remains the gating milestone before any commercial revenue can be generated.

Name

Socrates Health Solutions

Legal name

Socrates Health Solutions

Website

https://socrateshealthsolutions.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

1–10 employees

Short description

Socrates Health Solutions is a Dallas-based, pre-revenue medical device company founded in 2013 that develops non-invasive blood glucose monitoring hardware (CompanionCM, CompanionSR, CompanionLS) intended for people with diabetes, performance-minded consumers, and their caregivers, pending FDA clearance.

Ownership category

akta.pro rank

Product category

Non-Invasive Glucose Monitoring Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Blood Glucose Monitoring Devices (Consumer CGM & Smart Glucometers) (CRACAQAE)

akta.pro secondary industries

Blood Glucose Monitoring (BGM) Meters & Test Strips (HLAHAHAG), Hydration, Nutrition & Metabolic Tracking Devices (Smart Bottles, Breath/Metabolic Analyzers) (CRACAQAI)

Keywords

• Non-invasive glucose monitoring
• Continuous glucose monitor
• Diabetes management devices
• Pain-free blood glucose testing
• Wearable health monitoring

Headquarters

HQ city

Dallas

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Hardware Device Sales: Revenue expected from sale of proprietary non-invasive glucose monitoring devices including CompanionCM, CompanionSR, and CompanionLS. Products have not yet been cleared by FDA and are not currently for sale.

Go-to-market motion1 record

Marketing channels3 records

Core offering

Socrates Health Solutions develops the Companion line of non-invasive blood glucose monitoring devices — CompanionCM (continuous monitor), CompanionSR (single read), and CompanionLS (lifestyle) — that eliminate needle insertions and finger pricks for calibration while providing real-time glucose data, predictive alerts, and mobile data sharing for diabetes management and athletic performance. Products are pre-FDA-clearance and not yet for sale.

Product overview

Socrates Health Solutions offers the Socrates Companion platform, a non-invasive blood glucose monitoring system designed to be pain-free, accessible, and convenient for diabetes management and athletic performance. The product portfolio consists of three variants: CompanionCM (continuous glucose monitor for Type 1 diabetes), CompanionSR (single reading device for Type 2 diabetes), and CompanionLS (lifestyle continuous monitor for fitness and healthy living). All devices eliminate needles and finger pricks, provide real-time glucose information, and communicate with mobile devices. The products are not yet available and have not received FDA clearance.

Differentiator

Problem solved

Functional benefit

Brands

• Companion: Non-invasive blood glucose monitoring product line including CompanionCM (continuous monitor for Type 1 diabetes), CompanionSR (single read for Type 2 diabetes), and CompanionLS (lifestyle/fitness monitoring).
• CompanionCM
• CompanionSR
• CompanionLS

Products and services

• Socrates Companion (Platform)

Quantifiable outcome

• Products used in conjunction with insulin therapy and continuous glucose monitoring which help lower A1C

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Roche Diabetes Care: Major diabetes care player with Accu-Chek BGM and insulin delivery systems. Comparable to Socrates across the full diabetes management continuum and a likely strategic acquirer of novel non-invasive technology.
• LifeScan (OneTouch): Established BGM manufacturer (OneTouch) with global retail footprint and connected meter products. Directly comparable to Socrates' CompanionSR single-read use case for T2 diabetes patients.
• Ascensia Diabetes Care: Makes CONTOUR blood glucose meters for T2 diabetes. Comparable to Socrates in the single-read BGM segment and in pursuing connected, app-integrated meter experiences for non-intensive management.

Emerging players

• Senseonics (Eversense): Long-term implantable CGM (Eversense E3/Eversense 365). Comparable to Socrates as an alternative-architecture glucose sensor challenging incumbents on a different sensing approach, though implanted rather than non-invasive.
• Levels Health: Consumer-focused metabolic health company using CGM hardware plus software for fitness/lifestyle insight. Directly comparable to Socrates' CompanionLS use case targeting performance-minded and health-conscious non-diabetic consumers.
• Nutrisense: Subscription-based CGM service for metabolic health and weight management using off-the-shelf CGM sensors. Closely comparable to the wellness/lifestyle positioning of Socrates' CompanionLS and to recurring-revenue business models.

Direct peers

• Abbott Diabetes Care: Manufactures the FreeStyle Libre family of CGM sensors, the dominant volume player in CGM globally. Competes head-to-head with Socrates' CompanionCM/SR in the diabetes CGM and BGM segments and is expanding into consumer/wellness.
• Dexcom: Market-leading CGM manufacturer with G6/G7 continuous glucose monitors used by T1 and T2 diabetes patients. Directly comparable to Socrates' CompanionCM continuous monitor and sets the accuracy/reimbursement benchmark Socrates must meet.
• Medtronic Diabetes: Makes the Guardian Connect CGM and MiniMed insulin pump systems targeting intensive diabetes management. Direct peer for the T1D continuous monitoring and insulin-adjacent use case Socrates targets with CompanionCM.

Others

• Teladoc Health: Founding-board member Michael Gorton is also a Teladoc founder. Teladoc operates a connected-care platform where remote monitoring data from devices like Socrates' Companion could be ingested, making it an adjacent ecosystem participant and potential distribution partner.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights6 records

Customer concentration

• Xx.com/SocratesHealth
• Facebookfacebook.com/socrateshealthsolutions
• LinkedInlinkedin.com/company/socrates-health-solutions-inc-

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds4 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Socrates Health Solutions